Tarsus Pharmaceuticals (NASDAQ:TARS) is gearing up to announce its quarterly earnings on Monday, 2026-02-23. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Tarsus Pharmaceuticals will report an earnings per share (EPS) of $-0.07.
Anticipation surrounds Tarsus Pharmaceuticals’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Overview of Past Earnings
In the previous earnings release, the company beat EPS by $0.04, leading to a 4.62% drop in the share price the following trading …